448 results on '"Bufalo, Donatella"'
Search Results
2. Bcl-2 dependent modulation of Hippo pathway in cancer cells
3. Correction: Notch3-regulated microRNAs impair CXCR4-dependent maturation of thymocytes allowing maintenance and progression of T-ALL
4. Overview of BH3 mimetics in ovarian cancer
5. Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin
6. Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment
7. Phytochemical characterization and cytotoxic potential of extracts from roots and inflorescences of Cannabis sativa L. cv. Eletta Campana
8. Caspase-8 as a novel mediator linking Src kinase signaling to enhanced glioblastoma malignancy
9. Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance
10. Pharmacological targeting of CBP/p300 drives a redox/autophagy axis leading to senescence-induced growth arrest in non-small cell lung cancer cells
11. Bcl-2 family inhibitors sensitize human cancer models to therapy
12. Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models
13. SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma
14. New insights into the roles of antiapoptotic members of the Bcl-2 family in melanoma progression and therapy
15. LVI and DI-SPME Combined with GC/MS and GC/MS for Volatile Chemical Profile Investigation and Cytotoxic Power Evaluation of Essential Oil and Hydrolate from Cannabis sativa L. cv. Carmagnola.
16. Hypoxia-dependent drivers of melanoma progression
17. SEMAPHORINS and their receptors: focus on the crosstalk between melanoma and hypoxia
18. Antitumor effect of Melaleuca alternifolia essential oil and its main component terpinen-4-ol in combination with target therapy in melanoma models
19. Notch3-regulated microRNAs impair CXCR4-dependent maturation of thymocytes allowing maintenance and progression of T-ALL
20. Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells
21. Correction to: Targeting hypoxia in tumor: a new promising therapeutic strategy
22. microRNA-378a-5p iS a novel positive regulator of melanoma progression
23. Targeting hypoxia in tumor: a new promising therapeutic strategy
24. HMGA1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistance
25. First-in-Class Selective Inhibitors of the Lysine Acetyltransferase KAT8
26. Supplementary Figure 1 from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors
27. Supplementary Figure Legends from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors
28. Supplementary Figures 2 - 3 from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors
29. Data from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors
30. Supplementary Table 1 from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors
31. Supplementary Figures and Table with legends from Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS–Dependent Pancreatic Ductal Adenocarcinoma
32. Supplementary Materials and Methods from Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS–Dependent Pancreatic Ductal Adenocarcinoma
33. Data from Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS–Dependent Pancreatic Ductal Adenocarcinoma
34. Supplementary Figures 1-4 from CPTH6, a Thiazole Derivative, Induces Histone Hypoacetylation and Apoptosis in Human Leukemia Cells
35. Supplementary Methods, Figure Legends 1-4 from CPTH6, a Thiazole Derivative, Induces Histone Hypoacetylation and Apoptosis in Human Leukemia Cells
36. Correction: Zwergel et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. Cancers 2020, 12 , 447.
37. Bcl-2 family inhibitors sensitize human cancer models to target therapy
38. Phytochemicals as Immunomodulatory Agents in Melanoma
39. Volatile and Non-Volatile Content Determination and Biological Activity Evaluation of Fresh Humulus lupulus L. (cv. Chinook) Leaves and Inflorescences
40. Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb
41. Caspase-8 as a novel mediator linking Src kinase signaling to enhanced glioblastoma malignancy
42. Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance
43. Interleukin-8 in Colorectal Cancer: A Systematic Review and Meta-Analysis of Its Potential Role as a Prognostic Biomarker
44. Pharmacological targeting of CBP/p300 drives a redox/autophagy axis leading to senescence-induced growth arrest in non-small cell lung cancer cells
45. VEGF-induced neoangiogenesis is mediated by NAADP and two-pore channel-2-dependent Ca²⁺ signaling
46. Interleukin 8 mediates bcl‐xL‐induced enhancement of human melanoma cell dissemination and angiogenesis in a zebrafish xenograft model
47. A double point mutation at residues Ile14 and Val15 of Bcl‐2 uncovers a role for the BH4 domain in both protein stability and function
48. Pharmacological activation of SIRT6 triggers lethal autophagy in human cancer cells
49. Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models
50. Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.